Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 2.80 (8.24%)
Spread: 0.70 (1.913%)
Open: 35.00
High: 37.30
Low: 35.00
Prev. Close: 34.00
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Intu Properties Up As Consortium Makes Offer

Fri, 19th Oct 2018 10:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------London Stock Exchange Group, up 1.2%. LSEG said it will acquire a further 15% of LCH, taking its ownership to 80%. LSEG said the total cash consideration for the acquisition will be up to a maximum of EUR438 million. The acquisition will be funded from cash and existing debt facilities. The deal is expected to close before the end of 2018. In addition, for the three months ended September, LSEG reported a 7.4% increase in total income to GBP522 million from GBP486 million in the same period a year ago. The company's net revenue, which excludes income from the company's central counterparty business, increased 4.7% to GBP464 million from GBP443 million. LSEG's third-quarter gross profit increased 8.1% year-on-year to GBP465 million from GBP430 million.----------Evraz up 0.2%. The steel producer said its ongoing efficiency programme will result in a USD290 million to USD300 million gain on earnings before interest, taxes, depreciation and amortisation basis for 2018. Evraz is targeting to maintain its cost savings to improve cost of sales by at least 3% or around USD250 million to USD300 million per annum going forward. The company, which is holding an investor day on Friday, is considering four major investment projects to increase sales of finished steel products to local markets in In 2019 to 2022 period. It plans to invest between USD830 to USD990 million per annum during the period. For 2018, Evraz is guiding capital expenditure of USD640 million to USD660 million.----------FTSE 100 - LOSERS----------Intercontinental Hotels Group, down 7.0%. The hotel operator reported 1.0% rise in revenue per available room for the third quarter ended September, resulting from a 1.7% rise in room rates, offset by a 0.7% dip in occupancy. In Europe, Middle East, Asia & Africa, RevPAR was up 2.5% boosted by a good performance from Continental Europe, which saw RevPAR up 4.3%. EMEAA room rates were up 2.2% and occupancy by 0.3%. Also in Greater China RevPAR increased up 4.8% driven by continued transient and corporate demand, with room rates higher by 3.6% and occupancy by 1.2%. In addition, IHG said it will pay a USD500 million special dividend with a share consolidation in the first quarter of 2019.----------FTSE 250 - WINNERS----------intu Properties, up 12%. The property group confirmed that it had received a takeover proposal from a consortium comprising Peel Group, Olayan Group, and Brookfield Property Group. On Wednesday, intu received a revised proposal from the consortium of 215p per share in cash, it said. The terms of both the initial and revised proposals provide that the mooted consideration will be reduced by any dividends declared or paid by intu prior to completion of the deal. This includes intu's interim dividend of 4.6p per share, due to be paid in November. Accordingly, the consideration under the revised proposal would be 210.4p per share. That price values intu at GBP2.85 billion.----------Dechra Pharmaceuticals, up 4.7%. The group said that its trading in the first quarter was in line with management views with both units EU Pharmaceuticals and NA Pharmaceuticals recording "above market growth". The company said it is confident in the "continued out-performance" of the markets where it operates. In a separate announcement, Dechra said it bought Brazil-based Laboratorios Vencofarma for GBP37.8 million. Venco, which owns a portfolio of vaccines and food producing animal products, recorded GBP11.6 million in revenue for 2017. The firm, based in Londrina, Brazil, also owns a small range of companion animal products vaccines and pharmaceuticals.----------IP Group, up 2.3%. Berenberg initiated the intellectual property company with a Buy rating, and a target price of 160 pence.----------FTSE 250 - LOSERS----------Renishaw, down 7.4%. On Thursday, the engineering company reported a fall in pretax profit for the three months to the end of September by 9.2% to GBP33.5 million from GBP36.9 million in the first quarter of 2018. Renishaw's total revenue increased 8.2% to GBP154.0 million from GBP142.3 million in the same period last year. The company's Metrology division increased its revenue 7.5% in the first quarter to GBP147.4 million from GBP137.1 million. The company said it remains confident in its future prospects despite the "potential impacts" of Brexit and the "economic uncertainties" in Asia.----------Essentra, down 3.6%. The packaging and plastic products manufacturer said it will record a GBP12 million exceptional charge in the second half of 2018 due to the intended closure of the commercial print and consumer packaging site in Largo, US, as well as consultation processes at the company's commercial print facility in Kilmarnock and Nottingham in the UK. The Largo facility in Florida is expected to close by the end of 2018 and, if the proposals in the UK are confirmed, the Kilmarnock site would close and Speciality Tapes cease production in Nottingham by the same time.----------OTHER MAIN MARKET AND AIM - WINNERS----------Photonstar LED Group, up 15%. The LED lighting manufacturer has entered a partnership with a major housing association in the south of England to conduct a trial to assess the scalability of a number of products within Photonstar's V2 halcyon cloudBMS product suite to increase safety. The applications to be tested by the trial includes energy monitoring, critical assets monitoring, emergency lighting remote testing, temperature monitoring of water systems to reduce legionella risk and general environmental monitoring.----------Safestyle UK, up 14%. The windows and doors maker has confirmed that it is not in talks to acquire NIAMAC Developments, trading as SafeGlaze UK, or any of its business or assets. The board said it it is considering "other arrangements" with NIAMAC that could accelerate Safestyle's recovery. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Rockfire Resources, down 29%. The exploration company reported its reverse circulation drilling results at Marengo in Queensland, Australia, with the blind geophysical anomalies beneath and to the northeast of One Mile Mountain containing up to 1-2% pyrite, but hosts significant gold or copper in the two holes drilled.----------Futura Medical, down 27%. The sexual health-focused pharmaceutical company raised GBP5.6 million through a placing, subscription and open offer of shares at 7.0 pence per share. The price reflects a discount of 28% to Thursday's closing price of 9.65 pence. Proceeds will go towards funding its topical erectile dysfunction gel through to a phase three trial. The funds are also expected to allow more headroom in a long-term open label arm of the study, and to allow a second phase three trial to take place.----------Webis Holdings, down 18%. The pool wagering specialist said its US business, WatchandWager.com LLC has no choice but to end its wagering services to a syndicate following a commercial dispute. As a result, WatchandWager have refunded the syndicate's player balances, totalling USD10 million. This is expected to reduce Webis' gross margin for the year ending May 2019 by USD800,000.----------
More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

Read more
3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
Wednesday 10 April 
Churchill China PLCFull Year Results
Futura Medical PLCFull Year Results
M&C Saatchi PLCFull Year Results
Marshalls PLCFull Year Results
Tesco PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Read more
6 Feb 2024 17:04

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

Read more
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
6 Feb 2024 10:08

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Read more
15 Jan 2024 14:59

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Read more
15 Jan 2024 08:35

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

Read more
7 Nov 2023 17:47

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Oct 2023 12:21

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

Read more
19 Oct 2023 14:17

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Read more
2 Oct 2023 14:22

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Read more
2 Oct 2023 12:13

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

Read more
18 Sep 2023 11:28

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Sep 2023 15:44

UK earnings, trading statements calendar - next 7 days

Tuesday 12 September 
Associated British Foods PLCTrading Statement
Cornerstone FS PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Digital 9 Infrastructure PLCHalf Year Results
Dowlais Group PLCHalf Year Results
Eleco PLCHalf Year Results
Equals Group PLCHalf Year Results
Feedback PLCFull Year Results
Fevertree Drinks PLCHalf Year Results
Gym Group PLCHalf Year Results
Harworth Group PLCHalf Year Results
hVIVO PLCHalf Year Results
IQE PLCHalf Year Results
Itaconix PLCHalf Year Results
JTC PLCHalf Year Results
Keywords Studios PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocean Harvest Technology Group PLCHalf Year Results
Property Franchise Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Smart Metering Systems PLCHalf Year Results
Wednesday 13 September 
abrdn Smaller Companies Income Trust PLCHalf Year Results
Argentex Group PLCHalf Year Results
Brave Bison Group PLCHalf Year Results
Burford Capital LtdHalf Year Results
CAB Payments Holdings PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Frontier Developments PLCFull Year Results
Made Tech Group PLCFull Year Results
On The Beach Group PLCTrading Statement
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Ricardo PLCFull Year Results
Star Energy Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.